MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: TAC chemotherapy|DRUG: TC chemotherapy|DRUG: Dose Dense AC or FEC100 followed by paclitaxel or docetaxel chemotherapy|DRUG: TCH chemotherapy|DRUG: T + trastuzumab followed by CEF + trastuzumab|DRUG: Dose dense AC followed by T + trastuzumab|DRUG: Dose dense AC followed by T + trastuzumab + pertuzumab|DRUG: PTH followed by dose dense AC of FEC
Sponsor: Agendia
Collaborators: University of South Florida|University of Miami|Morton Plant Mease Health Care|AdventHealth|Plano Cancer Center|Ohio State University Comprehensive Cancer Center|University of Oklahoma|University of South Alabama